Janssen Pharmaceuticals
Founded Year
1993Stage
Acq - P2P | AcquiredValuation
$0000About Janssen Pharmaceuticals
Janssen Pharmaceuticals provides medicines for several therapeutic concerns. It includes Attention Deficit Hyperactivity Disorder (ADHD), general medicine including acid reflux disease, and infectious diseases, as well as mental health diseases such as bipolar disorder, schizophrenia, and many others. The company was founded in 1993 and is based in Leiden, Netherlands. In October 2010, Janssen Pharmaceuticals was acquired by Johnson & Johnson. The terms of the transaction were not disclosed.
Missing: Janssen Pharmaceuticals's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Janssen Pharmaceuticals's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Janssen Pharmaceuticals Patents
Janssen Pharmaceuticals has filed 148 patents.
The 3 most popular patent topics include:
- Immunology
- Vaccines
- Dosage forms

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
10/13/2020 | 3/21/2023 | Pharmacokinetics, Dosage forms, Drug delivery devices, Biotechnology, Nanotechnology | Grant |
Application Date | 10/13/2020 |
---|---|
Grant Date | 3/21/2023 |
Title | |
Related Topics | Pharmacokinetics, Dosage forms, Drug delivery devices, Biotechnology, Nanotechnology |
Status | Grant |
Latest Janssen Pharmaceuticals News
Mar 17, 2023
| AbbVie, Janssen Global Services News Provided By Share This Article BURLINGAME, CALIFORNIA, UNITED STATES, March 17, 2023 / EINPresswire.com / -- New Research Study "" Immunology Market 2023 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook"" has been added to Coherent Market Insight, Immunology is an important field of study that deals with the immune system and its response to diseases, infections, and other foreign substances. With the increasing prevalence of autoimmune diseases and cancer, there is a growing need for effective immunotherapy treatments that can stimulate the immune system to fight these diseases. Immunology drugs, also known as immunomodulators, are used to treat various diseases and conditions by either suppressing or boosting the immune system's response. For example, immunosuppressive drugs are used to treat autoimmune diseases such as lupus and rheumatoid arthritis, where the immune system attacks healthy tissues. On the other hand, immunostimulatory drugs, such as checkpoint inhibitors, are used to activate the immune system and fight cancer by targeting and killing cancerous cells. The global Immunology market size was valued at USD 91,850 million in 2022 and is anticipated to witness a compound annual growth rate (CAGR) of 8% from 2023 to 2030. Request a Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/4594 The global immunology market is expanding rapidly, driven by the growing prevalence of autoimmune diseases and cancer, as well as the increasing demand for effective immunotherapy treatments. In addition to immunology drugs, other immunotherapy treatments such as vaccines, cell therapies, and gene therapies are also being developed to target and treat various diseases. 𝗠𝗮𝗷𝗼𝗿 𝗞𝗲𝘆 𝗽𝗹𝗮𝘆𝗲𝗿𝘀 𝗶𝗻 𝘁𝗵𝗶𝘀 𝗠𝗮𝗿𝗸𝗲𝘁: ❖ AbbVie Inc. Report Scope This report aims to provide a comprehensive presentation of the global market for Immunology , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunology . The Immunology market size, estimations, and forecasts are provided in terms of sales volume and revenue, considering 2030 as the base year, with history and forecast data for the period from 2023 to 2030. This report segments the global Immunology market comprehensively. Regional market sizes, concerning products by types, application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The report will help the Immunology manufacturers, new entrants, and industry chain-related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Limited Period Offer | UP TO 45% Discount on Research Report @ Single User License : https://www.coherentmarketinsights.com/promo/buynow/4594 Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2023-2030. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Global Immunology Market: Regional Segmentation For a deeper understanding, the research report includes geographical segmentation of the global Immunology market. It provides an evaluation of the volatility of the political scenarios and amends likely to be made to the regulatory structures. This assessment gives an accurate analysis of the regional-wise growth of the global Immunology market. The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Immunology Market Most Critical Questions 1)What is the market size of the Immunology market at the global level? 2) Which screen size is most preferred by the consumers of Immunology ? 3) Which mode of distribution channel is most preferred by the manufacturers? 4) Which is the preferred age group for targeting Immunology for manufacturers? 5) What the key factors driving, inhibiting the growth of the market, and what is the degree of impact of the drivers and restraints? 6) What is the impact of the regulations on the growth of the Immunology market? 7) Which is the leading region/country for the market’s growth? What is the anticipated growth rate of the leading regions during the forecast period? 8) How are the emerging markets for Immunology expected to perform in the coming years? How is the consumption pattern expected to evolve in the future? 9) Who are the major players operating in the global Immunology market? What is the current market position of the key players? Who are the emerging players in this industry? Request PDF Brochure with Latest Insights:
Janssen Pharmaceuticals Frequently Asked Questions (FAQ)
When was Janssen Pharmaceuticals founded?
Janssen Pharmaceuticals was founded in 1993.
Where is Janssen Pharmaceuticals's headquarters?
Janssen Pharmaceuticals's headquarters is located at Archimedesweg 4-6, Leiden.
What is Janssen Pharmaceuticals's latest funding round?
Janssen Pharmaceuticals's latest funding round is Acq - P2P.
Who are the investors of Janssen Pharmaceuticals?
Investors of Janssen Pharmaceuticals include Johnson & Johnson, Leiden University and Alta Partners.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.